Starling Oncology Inc. Company Profile
NASDAQ: STLNHealth CareMedical/Nursing ServicesUSD
Market open · Delayed 15 min · as of Oct 8, 10:23 AM ET
Starling Oncology at a glance
Starling Oncology Inc. (NASDAQ: STLN) is a Medical/Nursing Services company in the Health Care sector headquartered in Cerritos, CA. Starling Oncology is led by Dr. Daniel Virnich FACHE, M.B.A., M.D. and employs about 641 people. The company's shares have traded publicly since 2020.
At a market capitalization of $655.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001799191, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Starling Oncology do?
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Business description based on the company's public filings.
Company information
- Legal name
- Starling Oncology Inc.
- Ticker
- NASDAQ: STLN
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Dr. Daniel Virnich FACHE, M.B.A., M.D.
- Employees
- 641
- Headquarters
- 18000 Studebaker Road, Cerritos, CA, United States
- Phone
- 562 735 3226
- Website
- starlingoncology.com
- IPO year
- 2020
- Market cap
- $655.32M
- SEC CIK
- 0001799191
- Latest annual report
- 10-K · Mar 12, 2026
Companies similar to Starling Oncology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SBCSBC Medical Group Holdings Incorporated | 5.18 | -3.00% | $532.75M | vs STLN |
| AHCOAdaptHealth Corp. | 5.91 | +0.51% | $788.45M | vs STLN |
| SRTAStrata Critical Medical Inc. Class A | 4.60 | -1.71% | $406.95M | vs STLN |
| AUNAAuna SA Class A | 5.08 | +0.59% | $376.21M | vs STLN |
| TDOCTeladoc Health Inc. | 5.50 | -1.17% | $998.35M | vs STLN |
| PIIIP3 Health Partners Inc. Class A | 5.63 | 0.00% | $1.15B | vs STLN |
| NAKANakamoto Inc. | 9.03 | -3.32% | $161.59M | vs STLN |
| LFMDLifeMD Inc. | 2.69 | -3.76% | $129.57M | vs STLN |